Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Shares Issued (2022 - 2025)

Historic Shares Issued for Prime Medicine (PRME) over the last 4 years, with Q3 2025 value amounting to $373000.0.

  • Prime Medicine's Shares Issued fell 9806.55% to $373000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $373000.0, marking a year-over-year decrease of 9902.55%. This contributed to the annual value of $38.1 million for FY2024, which is 571389.31% up from last year.
  • Prime Medicine's Shares Issued amounted to $373000.0 in Q3 2025, which was down 9806.55% from $19.3 million recorded in Q3 2024.
  • In the past 5 years, Prime Medicine's Shares Issued registered a high of $185.3 million during Q4 2022, and its lowest value of $63000.0 during Q3 2022.
  • For the 4-year period, Prime Medicine's Shares Issued averaged around $22.4 million, with its median value being $345500.0 (2023).
  • In the last 5 years, Prime Medicine's Shares Issued crashed by 9989.53% in 2023 and then surged by 2336666.67% in 2024.
  • Prime Medicine's Shares Issued (Quarter) stood at $185.3 million in 2022, then tumbled by 99.9% to $194000.0 in 2023, then soared by 9838.66% to $19.3 million in 2024, then plummeted by 98.07% to $373000.0 in 2025.
  • Its Shares Issued was $373000.0 in Q3 2025, compared to $19.3 million in Q3 2024 and $17.6 million in Q2 2024.